Abstract
Background
Brain natriuretic peptide (BNP) is increasingly being used for screening and monitoring of congestive heart failure. However, the role of BNP in patients with atrial fibrillation (AF) and normal left ventricular function has not been determined. This study investigates serum N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) level and its clinical implications in patients with AF.
Methods
Serum NT‐proBNP levels were measured by enzyme‐linked immunosorbent assay (ELISA) and transthoracic echocardiography was performed in 136 subjects (90 cases with AF and 46 cases with sinus rhythm [SR]). Subjects were excluded if they had a history of myocardial infarction, cardiomyopathy, rheumatic heart disease, or hyperthyroidism that preceded the onset of AF. Controls (n = 30) were from a healthy outpatient primary care population. Potential determinants of serum NT‐proBNP levels were identified by univariate and multivariate analyses.
Results
Individuals with AF had higher serum NT‐proBNP levels (689.56 ± 251.87 fmol/ml) than those with SR (456.11 ± 148.14 fmol/ml, P < 0.01) and control subjects (415.83 ± 62.02 fmol/ml, P < 0.01). Individuals with SR and control subjects did not show significant difference at serum NT‐proBNP levels (P > 0.05). The regression model of serum NT‐proBNP levels and clinical predictors showed that presence of AF, older age, and larger right atrial diameter were independently predictive of higher serum NT‐proBNP values.
Conclusions
Patients with AF were associated with increased serum NT‐proBNP levels. Examining the change of serum NT‐proBNP levels is helpful to evaluate the cardiac function in patients with AF. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (106.8 KB).
References
- 1. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998; 98: 946–952. [DOI] [PubMed] [Google Scholar]
- 2. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 2000; 64: 765–771. [DOI] [PubMed] [Google Scholar]
- 3. Shimizu H, Murakami Y, Inoue S, et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 2002; 33: 1005–1010. [DOI] [PubMed] [Google Scholar]
- 4. Horie H, Tsutamoto T, Minai K, et al. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Circ J 2000; 64: 965–970. [DOI] [PubMed] [Google Scholar]
- 5. Wazni OM, Martin DO, Marrouche NF, et al. Plasma B‐type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004; 110: 124–127. [DOI] [PubMed] [Google Scholar]
- 6. Ogawa Y, Itoh H, Nakao K. Molecular biology and biochemistry of natriuretic peptide family. Clin Exp Pharmacol Physiol 1995; 22: 49–53. [DOI] [PubMed] [Google Scholar]
- 7. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000; 6: 92–96. [DOI] [PubMed] [Google Scholar]
- 8. Tuinenburg AE, Brundel BJ, Van Gelder IC, et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999; 10: 827–835. [DOI] [PubMed] [Google Scholar]
- 9. Rossi A, Enriquez‐Sarano M, Burnett JC Jr, et al. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler‐echocardiographic study. J Am Coll Cardiol 2000; 35: 1256–1262. [DOI] [PubMed] [Google Scholar]
- 10. Silvet H, Young‐Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003; 92: 1124–1127. [DOI] [PubMed] [Google Scholar]
- 11. Jourdain P, Bellorini M, Funck F, et al. Short‐term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 2002; 4: 263–267. [DOI] [PubMed] [Google Scholar]
- 12. Ohta Y, Shimada T, Yoshitomi H, et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 2001; 17: 415–420. [PubMed] [Google Scholar]
- 13. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005; 45: 82–86. [DOI] [PubMed] [Google Scholar]
- 14. Wozakowska‐Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004; 93: 1555–1558. [DOI] [PubMed] [Google Scholar]
- 15. Luchner A, Burnett JC Jr, Jougasaki M, et al. Augmentation of the cardiac natriuretic peptide by β ‐receptor antagonism: evidence from a population‐based study. J Am Coll Cardiol 1998; 32: 1839–1844. [DOI] [PubMed] [Google Scholar]
- 16. Davis ME, Richards AM, Nicholls MG, et al. Introduction of metoprolol increases plasma B‐type cardiac natriuretic peptides in mild, stable heart failure. Circulation 2006; 113: 977–985. [DOI] [PubMed] [Google Scholar]
- 17. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide in elderly population. J Inter Med 1997; 242: 307–311. [DOI] [PubMed] [Google Scholar]